DAVITA INC. Business Acquisition, Pro Forma Net Income (Loss) (Deprecated 2011-01-31)
DAVITA INC. (DVA) reported Business Acquisition, Pro Forma Net Income (Loss) (Deprecated 2011-01-31) of $417.82 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionProFormaNetIncomeLoss · last filed 2011-02-25
- DAVITA INC. business acquisition, pro forma net income (loss) (deprecated 2011-01-31) for fiscal 2010 was $417.82M, a 4.26% decline from fiscal 2009.
- DAVITA INC. business acquisition, pro forma net income (loss) (deprecated 2011-01-31) for fiscal 2009 was $436.42M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) (Deprecated 2011-01-31) 12 month |
|---|---|
| 2010-12-31 | $417.82M 10-K · filed 2011-02-25 |
| 2009-12-31 | $436.42M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |